Warning: The NCBI web site requires JavaScript to function. more...
High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?
Sims AH, Ong KR, Clarke RB, Howell A.
Breast Cancer Res. 2006;8(5):214. Review.
Related citations
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F, Reis-Filho JS.
Int J Surg Pathol. 2009 Aug;17(4):285-302. Epub 2008 Dec 22. Review.
[Genome-wide expression profiling as a clinical tool: are we there yet?].
Geyer FC, Decker T, Reis-Filho JS.
Pathologe. 2009 Mar;30(2):141-6. Review. German.
The promise of microarrays in the management and treatment of breast cancer.
Chang JC, Hilsenbeck SG, Fuqua SA.
Breast Cancer Res. 2005;7(3):100-4. Epub 2005 Apr 1. Review.
Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us?
Sims AH.
J Clin Pathol. 2009 Oct;62(10):879-85. Epub 2009 Jan 27. Review.
Microarrays in breast cancer research and clinical practice--the future lies ahead.
Gruvberger-Saal SK, Cunliffe HE, Carr KM, Hedenfalk IA.
Endocr Relat Cancer. 2006 Dec;13(4):1017-31. Review.
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
Sotiriou C, Piccart MJ.
Nat Rev Cancer. 2007 Jul;7(7):545-53. Review.
Expression profiling technology: its contribution to our understanding of breast cancer.
Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO.
Histopathology. 2008 Jan;52(1):67-81. Review.
Gene expression profiling in breast cancer: towards individualising patient management.
Murphy N, Millar E, Lee CS.
Pathology. 2005 Aug;37(4):271-7. Review.
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P, Campone M, Roché H, Gouraud W, Charbonnel C, Ricolleau G, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Campion L.
Breast Cancer Res Treat. 2009 Aug;116(3):509-20. Epub 2008 Nov 20.
Breast cancer gene expression profiling: clinical trial and practice implications.
Loi S, Desmedt C, Cardoso F, Piccart M, Sotiriou C.
Pharmacogenomics. 2005 Jan;6(1):49-58. Review.
The impact of expression profiling on prognostic and predictive testing in breast cancer.
Reis-Filho JS, Westbury C, Pierga JY.
J Clin Pathol. 2006 Mar;59(3):225-31. Review.
[Has the time arrived for gene expression use at the bedside?].
D'Hondt V, Piccart M, Sotiriou C.
Bull Cancer. 2008 Mar;95(3):336-43. Review. French.
Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP.
Expert Rev Mol Diagn. 2007 May;7(3):269-80. Review.
Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
Modlich O, Prisack HB, Bojar H.
Expert Opin Pharmacother. 2006 Oct;7(15):2069-78. Review.
[Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.
Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.
Molecular profiling of breast cancer: portraits but not physiognomy.
Brenton JD, Aparicio SA, Caldas C.
Breast Cancer Res. 2001;3(2):77-80. Epub 2000 Dec 18. Review.
Gene expression profiling of breast cancer.
Cheang MC, van de Rijn M, Nielsen TO.
Annu Rev Pathol. 2008;3:67-97. Review.
Gene expression profiling of primary breast cancer.
Rouzier R, Wagner P, Morandi P, Pusztai L.
Curr Oncol Rep. 2005 Jan;7(1):38-44. Review.
Biomolecular features of clinical relevance in breast cancer.
Daidone MG, Paradiso A, Gion M, Harbeck N, Sweep F, Schmitt M.
Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S3-14. Epub 2004 Apr 17. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on